Targeting the Glutamatergic System for the Development of Novel Antidepressant Treatments: Pathophysiologically Informed Drug Development
Gerard Sanacora, MD, PHD
Professor, Department of Psychiatry
Yale University, School of Medicine
Director, Yale Depression Research Program
Click here to view the archived webcast - 
.
